DUBLIN--(BUSINESS WIRE)--The "North America Dietary Supplements Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The North America Dietary Supplements Market is expected to witness market growth of 9.7% CAGR during the forecast period (2017-2023).
Easy availability of sports nutrition products in supermarkets and convenience stores is expected to drive the market demand.
Awareness about functional foods to remain healthy and reduce the risk of cholesterol related diseases is expected to significantly add to the Dietary Supplements market.
However, the introduction of new nutraceutical products such as yogurt, fresh bread, cereal bars and frozen baked foods are the factors that is expected to limit the market expansion.
Based on Product, the Dietary Supplements market segments the market into Tablets & Capsules, Powder, Liquids, Soft Gels, and Others.
Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others.
Based on End-User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman.
Based on Regions, the Dietary Supplements market segments the market into US, Mexico, Canada, and Rest of North America.
Key Topics Covered
1. Market Scope & Methodology
2. Market Overview
3. North America Dietary Supplements Market
4. North America Dietary Supplements Market by Ingredients
5. North America Dietary Supplements Market by End-User
6. North America Dietary Supplements Market by Country
7. Company Profiles
- Abbott Laboratories
- The Carlyle Group
- GlaxoSmithKline plc
- Alticor (Amway)
- Glanbia, Plc. (Glanbia Nutritionals)
- Bayer AG
- Archer Daniels Midland Company
- E. I. Du Pont De Nemours and Company
- Nutraceutics Inc.
- Pfizer, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/dxhw8q/north_american?w=4